Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.31M | -1.97M | -1.62M | -1.62M | -1.60M |
| Total Depreciation and Amortization | 91.90K | 115.50K | 139.60K | 138.80K | 137.20K |
| Total Amortization of Deferred Charges | 213.40K | 162.20K | 110.10K | 69.60K | 28.40K |
| Total Other Non-Cash Items | 1.29M | 806.60K | 318.00K | 275.80K | 233.30K |
| Change in Net Operating Assets | 102.80K | -249.90K | -609.20K | -450.50K | -294.70K |
| Cash from Operations | -609.60K | -1.13M | -1.67M | -1.58M | -1.49M |
| Capital Expenditure | -11.70K | -7.80K | -3.80K | -7.60K | -11.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.20K | -83.50K | -154.10K | -303.10K | -447.70K |
| Cash from Investing | -25.80K | -91.20K | -157.90K | -310.70K | -458.90K |
| Total Debt Issued | 109.00K | 90.50K | 72.00K | 161.00K | 250.00K |
| Total Debt Repaid | -58.00K | -92.50K | -127.00K | -142.50K | -158.00K |
| Issuance of Common Stock | -- | 943.50K | 1.89M | 1.89M | 1.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -96.50K | -193.00K | -193.00K | -193.00K |
| Cash from Financing | 64.70K | 1.05M | 2.06M | 2.15M | 2.24M |
| Foreign Exchange rate Adjustments | -17.10K | 10.70K | 39.00K | 27.70K | 16.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -587.90K | -162.70K | 270.60K | 281.90K | 301.20K |